Among these proteins, S100A8 and S100A9, in particular, are involved in inflammation and cancer [2]; these two proteins activate the MAP kinase and NF-κB signaling pathways, trigger translocation of the RAGE receptor in human prostate cancer cells [3], and activate Toll-like receptor 4 [4], [5]. This evidence concerns the gene S100A9 and prostate cancer.